activities amounts to EUR 133.7 million 
(2022: EUR 88.5 million), showing a 
significant increase of 51.1% thanks to a 
good backlog conversion with a high 
delivery volume and a solid order intake 
in H1; === Page 131 ===
IBA Annual Report 2023 
128. revenues for the Dosimetry segment of EUR 
65.9 million, a strong 22.1% increase from 
2022 (2022: EUR 54.0 million) from organic 
and external growth following the acquisition 
of Modus in 2022.